Cargando…

Whole genome analysis identifies the association of TP53 genomic deletions with lower survival in Stage III colorectal cancer

DNA copy number aberrations (CNA) are frequently observed in colorectal cancers (CRC). There is an urgent need for CNA-based biomarkers in clinics,. n For Stage III CRC, if combined with imaging or pathologic evidence, these markers promise more precise care. We conducted this Stage III specific bio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xia, Li C., Van Hummelen, Paul, Kubit, Matthew, Lee, HoJoon, Bell, John M., Grimes, Susan M., Wood-Bouwens, Christina, Greer, Stephanie U., Barker, Tyler, Haslem, Derrick S., Ford, James M., Fulde, Gail, Ji, Hanlee P., Nadauld, Lincoln D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7081316/ https://www.ncbi.nlm.nih.gov/pubmed/32193467 http://dx.doi.org/10.1038/s41598-020-61643-6

Ejemplares similares

Characterization of the consensus mucosal microbiome of colorectal cancer
por: Zhao, Lan, et al.
Publicado: (2021)

Precision Oncology Strategy in Trastuzumab-Resistant Human Epidermal Growth Factor Receptor 2–Positive Colon Cancer: Case Report of Durable Response to Ado-Trastuzumab Emtansine
por: Haslem, Derrick S., et al.
Publicado: (2017)

Precision oncology in advanced cancer patients improves overall survival with lower weekly healthcare costs
por: Haslem, Derrick S., et al.
Publicado: (2018)

Linked read sequencing resolves complex genomic rearrangements in gastric cancer metastases
por: Greer, Stephanie U., et al.
Publicado: (2017)

An elevated neutrophil-to-lymphocyte ratio associates with weight loss and cachexia in cancer
por: Barker, Tyler, et al.
Publicado: (2020)

Universal Germline Testing of Unselected Cancer Patients Detects Pathogenic Variants Missed by Standard Guidelines without Increasing Healthcare Costs
por: Perkins, Adrienne T., et al.
Publicado: (2021)

Germline variants of ATG7 in familial cholangiocarcinoma alter autophagy and p62
por: Greer, Stephanie U., et al.
Publicado: (2022)

KmerKeys: a web resource for searching indexed genome assemblies and variants
por: Pavlichin, Dmitri S, et al.
Publicado: (2022)

The Cancer Genome Atlas Clinical Explorer: a web and mobile interface for identifying clinical–genomic driver associations
por: Lee, HoJoon, et al.
Publicado: (2015)

A Retrospective Analysis of Precision Medicine Outcomes in Patients With Advanced Cancer Reveals Improved Progression-Free Survival Without Increased Health Care Costs
por: Haslem, Derrick S., et al.
Publicado: (2017)

Deletions of 9p21 and TP53 in bladder cancer.
por: Park, W. S., et al.
Publicado: (1996)

Genomic landscape of TP53-mutated myeloid malignancies
por: Abel, Haley J., et al.
Publicado: (2023)

Genomic landscape of TP53-mutated myeloid malignancies
por: Abel, Haley J., et al.
Publicado: (2023)

TP-0903 Is Active in Preclinical Models of Acute Myeloid Leukemia with TP53 Mutation/Deletion
por: Eisenmann, Eric D., et al.
Publicado: (2022)

Unique k-mer sequences for validating cancer-related substitution, insertion and deletion mutations
por: Lee, HoJoon, et al.
Publicado: (2020)

Systematic genomic identification of colorectal cancer genes delineating advanced from early clinical stage and metastasis
por: Lee, HoJoon, et al.
Publicado: (2013)

Single-Color Digital PCR Provides High-Performance Detection of Cancer Mutations from Circulating DNA
por: Wood-Bouwens, Christina, et al.
Publicado: (2017)

A genome-wide approach for detecting novel insertion-deletion variants of mid-range size
por: Xia, Li C., et al.
Publicado: (2016)

Clinical Utility of Genomic Testing in Cancer Care
por: Pritchard, Daryl, et al.
Publicado: (2022)

Clinical implications of cytogenetic heterogeneity in multiple myeloma patients with TP53 deletion
por: Hao, Suyang, et al.
Publicado: (2017)

Genomic Characterization of TP53–Wild-Type Esophageal Carcinoma()
por: Quaas, Alexander, et al.
Publicado: (2018)

MendeLIMS: a web-based laboratory information management system for clinical genome sequencing
por: Grimes, Susan M, et al.
Publicado: (2014)

Genomic alterations associated with loss of heterozygosity for TP53 in Li-Fraumeni syndrome fibroblasts
por: Burt, E C, et al.
Publicado: (2000)

Mitigating the Risk of t-MNs Development: TP53 or Not TP53?
por: Tesio, Melania
Publicado: (2023)

The TP53 website: an integrative resource centre for the TP53 mutation database and TP53 mutant analysis
por: Leroy, Bernard, et al.
Publicado: (2013)

Myeloid malignancies with 5q and 7q deletions are associated with extreme genomic complexity, biallelic TP53 variants, and very poor prognosis
por: Pitel, Beth A., et al.
Publicado: (2021)

Genome-wide characterization reveals complex interplay between TP53 and TP63 in response to genotoxic stress
por: McDade, Simon S., et al.
Publicado: (2014)

From uncertainty to pathogenicity: clinical and functional interrogation of a rare TP53 in-frame deletion
por: Quinn, Emily A., et al.
Publicado: (2019)

Genomic Analysis Revealed New Oncogenic Signatures in TP53-Mutant Hepatocellular Carcinoma
por: Kancherla, Venkatesh, et al.
Publicado: (2018)

Development of chronic myelogenous leukemia in a case of chronic lymphocytic leukemia with Tp53 gene deletion
por: Gupta, A, et al.
Publicado: (2015)

TP53 and TP53-associated genes are correlated with the prognosis of paediatric neuroblastoma
por: Wang, Haiwei, et al.
Publicado: (2022)

Identification of large rearrangements in cancer genomes with barcode linked reads
por: Xia, Li C, et al.
Publicado: (2018)

Expression of TP53 Isoforms p53β or p53γ Enhances Chemosensitivity in TP53(null) Cell Lines
por: Silden, Elisabeth, et al.
Publicado: (2013)

Interrelationship between TP53 gene deletion, protein expression and chromosome 17 aneusomy in gastric adenocarcinoma
por: Khayat, André S, et al.
Publicado: (2009)

Genomic Instability and TP53 Genomic Alterations Associate With Poor Antiproliferative Response and Intrinsic Resistance to Aromatase Inhibitor Treatment
por: Schuster, Eugene F., et al.
Publicado: (2019)

TP53 Combined Phenotype Score Is Associated with the Clinical Outcome of TP53-Mutated Myelodysplastic Syndromes
por: Yabe, Mariko, et al.
Publicado: (2021)

Non-Nodal CD5-Negative Mantle Cell Lymphoma with Secondary TP53 Deletion
por: McCall, Robert K., et al.
Publicado: (2020)

Repurposing auranofin to treat TP53-mutated or PTEN-deleted refractory B-cell lymphoma
por: Wang, Jeffrey, et al.
Publicado: (2019)

SVEngine: an efficient and versatile simulator of genome structural variations with features of cancer clonal evolution
por: Xia, Li Charlie, et al.
Publicado: (2018)

Optimisation of TP53 reporters by systematic dissection of synthetic TP53 response elements
por: Trauernicht, Max, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_1pdbj95nnc7kvu0tdoudlbutoc